• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

• C
• Carnovale, Miriam
  IFF
• (M1330-01-03) FM1000 Surfactant is Compatible with Downstream Bioprocessing
  Miriam Carnovale
  Favorite
• Catalano, Al
  BioAgilytix Labs, LLC.
• (T1130-01-02) Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
  Al Catalano
  Favorite
• Chaly, Yury
  Bristol-Myers Squibb Company
• (T1330-01-02) Screening and Epitope Binning of Anti-idiotypic Antibodies against Therapeutic Bispecific Antibodies Using the Gyros Immunoassay Platform
  Yury Chaly
  Favorite
• Chappell, John
  Gyros Protein Technologies
• (M1030-01-01) Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
  John Chappell
  Favorite
• (T1130-01-01) Strategies for Measuring Oligonucleotides Using a Fully Automated Microfluidic Immunoassay System
  John Chappell
  Favorite
• Chase, Liam
  University of Pennsylvania
• (T1030-01-08) Conjugation Chemistry Used to Construct Protein-Coated Nanoparticles Determines Complement Activation and Associated Efficacy and Toxicity
  Liam Chase
  Favorite
• Cheng, Sau Wan
  Chinese University of Hong Kong
• (T1130-01-09) Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
  Sau Wan Cheng
  Favorite
• Chen, Hong
  Alliance Pharma Inc.
• (M1130-01-08) Establishment of a Generic ADA Assay for Detection of Anti-Drug Antibody Specific to Human IgG Derived Drug Candidate in Murine Serum Samples
  Hong Chen
  Favorite
• (T1130-01-08) Labelling AAV5 Capsid Reduced Its Binding Affinity to the Anti-AAV5 Antibody in Non-primate Human Serum Samples
  Hong Chen
  Favorite
• (T1430-01-04) A Sensitive Electrochemiluminescence-Based Method for the Detection of Anti-drug Antibodies against Anti-PD-1 Antibody Drug Pembrolizumab in Human Serum
  Hong Chen
  Favorite
• Chen, Ming-Luan
  Altasciences
• (M1330-01-05) Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides
  Ming-Luan Chen
  Favorite
• Coddington, Ashley
  PPD, a part of Thermo Fisher Scientific
• (M1030-01-05) Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
  Ashley Coddington
  Favorite
• Cookson, Colt
  Veloxity Labs, LLC
• (M1430-01-05) Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
  Colt Cookson
  Favorite
• Corpstein, Clairissa D.
  Purdue University
• (M1130-01-02) Multiscale Pharmacokinetic Modeling and Simulation of Local and Systemic Exposure of Intramuscularly Injected LNPs
  Clairissa D. Corpstein
  Favorite
• Craig, Caryn
  PPD Laboratories
• (M1430-01-01) Discrepancies in Adeno-Associated Virus Serotype and Isotype Characterization Positivity Rates in Cynomolgus Serum
  Caryn Craig
  Favorite
• Craig, Jane
  Labcorp Drug Development
• (M1330-01-02) A Robust Adoptive Cell Therapy Phenotyping Panel for Assessing Cerebrospinal Fluid During and After Neurotoxicity by Flow Cytometry
  Jane Craig
  Favorite
• Creamer, Luke
  Alliance Pharma Inc.
• (T1430-01-04) A Sensitive Electrochemiluminescence-Based Method for the Detection of Anti-drug Antibodies against Anti-PD-1 Antibody Drug Pembrolizumab in Human Serum
  Luke Creamer
  Favorite
• Cross, Abigail
  PPD, a part of Thermo Fisher Scientific
• (M1030-01-05) Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
  Abigail Cross
  Favorite
• Crowe, Molly
  PPD Laboratories
• (M1430-01-01) Discrepancies in Adeno-Associated Virus Serotype and Isotype Characterization Positivity Rates in Cynomolgus Serum
  Molly Crowe
  Favorite
• Czepczor, Valerie
  Sanofi
• (M1330-01-06) In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
  Valerie Czepczor
  Favorite